NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Ear Disease


Return to Library

Free Ear Disease Articles


New ear disease data have been reported by D. Horlbeck and co-authors



2009 MAY 19 - (NewsRx.com) -- "The purpose of this study was to determine the efficacy of treating chronic ear disease by performing it single surgical intervention in the austere environment of a developing nation. Data were collected from retrospective chart reviews on 12 1 patients who underwent Surgical treatment of chronic ear disease during, humanitarian surgical missions in South and Central America," investigators in the United States report.

"Surgical outcomes and clinical course were assessed at 10 to 12 months after the initial surgery. A total of 117 patients were included in the Study. Follow-up records were available for 75 patients (64%). A total of 20 surgeries were performed for dry perforations (group 1), 30 for chronically draining cars (group 2). and 25 for cholesteatomas (group 3). Surgical success was determined as 60 percent, 74 percent, and 92 percent for groups 1, 2, and 3, respectively," wrote D. Horlbeck and colleagues.

The researchers concluded: "Surgical results during international otologic outreach missions to developing nations fall within the results expected in developed nations."

Horlbeck and colleagues published their study in Otolaryngology - Head and Neck Surgery (Humanitarian otologic missions: Long-term surgical results. Otolaryngology - Head and Neck Surgery, 2009;140(4):559-565).

For additional information, contact D. Horlbeck, Nemours Children's Clinic, Division Otolaryngology, Jacksonville, FL 32207, USA.

The publisher of the journal Otolaryngology - Head and Neck Surgery can be contacted at: Mosby-Elsevier, 360 Park Avenue South, New York, NY 10010-1710, USA.

Keywords: United States, Jacksonville, Ear Disease, Laryngology, Otolaryngology, Surgery.

This article was prepared by Life Science Weekly editors from staff and other reports. Copyright 2009, Life Science Weekly via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login